drugset / Trial / NCT01905540
A Relative Bioavailability Study of SSP-004184AQ (Magnesium Salt) and SSP-004184SS (Disodium Salt)
RandomizedCrossoverOpen-labelTreatment
Summary
This study will evaluate the relative bioavailability of the new SSP-004184SS capsule formulation compared to the original SSP-004184AQ drug plus excipients formulation.
Timeline
- Start
- 2013-08-05
- Primary completion
- 2013-09-20
- Completion
- 2013-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DEFERITAZOLE | Small molecule | 21.8 mg/kg | Oral |
| Subject | DEFERITAZOLE | Small molecule | 40 mg/kg | Oral |
Indications
No indication recorded.